• Je něco špatně v tomto záznamu ?

Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies

R. Alaghehbandan, K. Trpkov, M. Tretiakova, AS. Luis, JD. Rogala, O. Hes

. 2021 ; 28 (1) : 8-20. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019490

Chromophobe renal cell carcinoma (ChRCC) accounts for 5% to 7% of all renal cell carcinomas. It was thought for many years that ChRCC exhibits a hypodiploid genome. Recent studies using advanced molecular genetics techniques have shown more complex and heterogenous pattern with frequent chromosomal gains. Historically, multiple losses of chromosomes 1, 2, 6, 10, 13, 17, and 21 have been considered a genetic hallmark of ChRCC, both for classic and eosinophilic ChRCC variants. In the last 2 decades, multiple chromosomal gains in ChRCCs have also been documented, depicting a considerably broader genetic spectrum than previously thought. Studies of rare morphologic variants including ChRCC with pigmented microcystic adenomatoid/multicystic growth, ChRCC with neuroendocrine differentiation, ChRCC with papillary architecture, and renal oncocytoma-like variants also showed variable chromosomal numerical aberrations, including multiple losses (common), gains (less common), or chromosomal changes overlapping with renal oncocytoma. Although not the focus of the review, The Cancer Genome Atlas (TCGA) data in ChRCC show TP53, PTEN, and CDKN2A to be the most mutated genes. Given the complexity of molecular genetic alterations in ChRCC, this review analyzed the existing published data, aiming to present a comprehensive up-to-date survey of the chromosomal abnormalities in classic ChRCC and its variants. The potential role of chromosomal numerical aberrations in the differential diagnostic evaluation may be limited, potentially owing to its high variability.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019490
003      
CZ-PrNML
005      
20210830101049.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/PAP.0000000000000286 $2 doi
035    __
$a (PubMed)33021507
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Alaghehbandan, Reza $u Department of Pathology, Faculty of Medicine, Royal Columbian Hospital, University of British Columbia, Vancouver, BC
245    10
$a Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies / $c R. Alaghehbandan, K. Trpkov, M. Tretiakova, AS. Luis, JD. Rogala, O. Hes
520    9_
$a Chromophobe renal cell carcinoma (ChRCC) accounts for 5% to 7% of all renal cell carcinomas. It was thought for many years that ChRCC exhibits a hypodiploid genome. Recent studies using advanced molecular genetics techniques have shown more complex and heterogenous pattern with frequent chromosomal gains. Historically, multiple losses of chromosomes 1, 2, 6, 10, 13, 17, and 21 have been considered a genetic hallmark of ChRCC, both for classic and eosinophilic ChRCC variants. In the last 2 decades, multiple chromosomal gains in ChRCCs have also been documented, depicting a considerably broader genetic spectrum than previously thought. Studies of rare morphologic variants including ChRCC with pigmented microcystic adenomatoid/multicystic growth, ChRCC with neuroendocrine differentiation, ChRCC with papillary architecture, and renal oncocytoma-like variants also showed variable chromosomal numerical aberrations, including multiple losses (common), gains (less common), or chromosomal changes overlapping with renal oncocytoma. Although not the focus of the review, The Cancer Genome Atlas (TCGA) data in ChRCC show TP53, PTEN, and CDKN2A to be the most mutated genes. Given the complexity of molecular genetic alterations in ChRCC, this review analyzed the existing published data, aiming to present a comprehensive up-to-date survey of the chromosomal abnormalities in classic ChRCC and its variants. The potential role of chromosomal numerical aberrations in the differential diagnostic evaluation may be limited, potentially owing to its high variability.
650    _2
$a nádorové biomarkery $7 D014408
650    _2
$a karcinom z renálních buněk $x genetika $x patologie $7 D002292
650    12
$a chromozomální aberace $7 D002869
650    _2
$a geny p16 $7 D019942
650    _2
$a geny p53 $7 D016158
650    _2
$a lidé $7 D006801
650    _2
$a nádory ledvin $x genetika $x patologie $7 D007680
650    _2
$a fosfohydroláza PTEN $x genetika $7 D051059
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Trpkov, Kiril $u Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada
700    1_
$a Tretiakova, Maria $u Department of Pathology, University of Washington, Seattle, WA
700    1_
$a Luis, Ana S $u Department of Pathology, Portuguese Institute of Oncology of Porto Francisco Gentil, Porto, Portugal
700    1_
$a Rogala, Joanna D $u Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Plzen, Plzen, Czech Republic
700    1_
$a Hes, Ondrej $u Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Plzen, Plzen, Czech Republic
773    0_
$w MED00000158 $t Advances in anatomic pathology $x 1533-4031 $g Roč. 28, č. 1 (2021), s. 8-20
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33021507 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101049 $b ABA008
999    __
$a ok $b bmc $g 1690337 $s 1139936
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 1 $d 8-20 $e - $i 1533-4031 $m Advances in anatomic pathology $n Adv Anat Pathol $x MED00000158
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace